# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
To fight the mpox outbreak in Africa, the World Health Organization calls for funding help for its six-month plan.
https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-member-states-information-sessio...
Rodman & Renshaw initiates coverage on Emergent BioSolutions (NYSE:EBS) with a Buy rating and announces Price Target of $16.
https://www.fox2detroit.com/news/mpox-wayne-county-health-department-confirms-first-case-since-2022?taid=66c643be103e400001efc3...
- Reuters